Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Analysis of medication-related malpractice claims: causes, preventability, and costs.

Rothschild JM, Federico FA, Gandhi TK, Kaushal R, Williams DH, Bates DW.

Arch Intern Med. 2002 Nov 25;162(21):2414-20.

PMID:
12437399
[PubMed - indexed for MEDLINE]
2.

The epidemiology of preventable adverse drug events: a review of the literature.

von Laue NC, Schwappach DL, Koeck CM.

Wien Klin Wochenschr. 2003 Jul 15;115(12):407-15. Review.

PMID:
12918183
[PubMed - indexed for MEDLINE]
3.

Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care.

Thomsen LA, Winterstein AG, Søndergaard B, Haugbølle LS, Melander A.

Ann Pharmacother. 2007 Sep;41(9):1411-26. Epub 2007 Jul 31. Review.

PMID:
17666582
[PubMed - indexed for MEDLINE]
4.

Potential risks and prevention, Part 1: Fatal adverse drug events.

Kelly WN.

Am J Health Syst Pharm. 2001 Jul 15;58(14):1317-24. Review.

PMID:
11471479
[PubMed - indexed for MEDLINE]
5.

Adverse drug events and medication errors in Australia.

Runciman WB, Roughead EE, Semple SJ, Adams RJ.

Int J Qual Health Care. 2003 Dec;15 Suppl 1:i49-59. Review.

PMID:
14660523
[PubMed - indexed for MEDLINE]
Free Article
6.

Drug-related problems and adverse drug events: negligence, litigation and prevention.

Bhatt AD.

J Assoc Physicians India. 1999 Jul;47(7):715-20. Review.

PMID:
10778594
[PubMed - indexed for MEDLINE]
7.

What do we know about medication errors in inpatient psychiatry?

Grasso BC, Rothschild JM, Genest R, Bates DW.

Jt Comm J Qual Saf. 2003 Aug;29(8):391-400. Review.

PMID:
12953603
[PubMed - indexed for MEDLINE]
8.

Identifying drug safety issues: from research to practice.

Gandhi TK, Seger DL, Bates DW.

Int J Qual Health Care. 2000 Feb;12(1):69-76. Review.

PMID:
10733086
[PubMed - indexed for MEDLINE]
Free Article
9.

Medical errors challenges for the health professionals: need of Pharmacovigilance to prevent.

Das BP, Rauniar GP, Bhattacharya SK.

JNMA J Nepal Med Assoc. 2006 Apr-Jun;45(162):273-8. Review.

PMID:
18365356
[PubMed - indexed for MEDLINE]
10.

Methods for assessing the preventability of adverse drug events: a systematic review.

Hakkarainen KM, Andersson Sundell K, Petzold M, Hägg S.

Drug Saf. 2012 Feb 1;35(2):105-26. doi: 10.2165/11596570-000000000-00000. Review.

PMID:
22201475
[PubMed - indexed for MEDLINE]
11.

Potential risks and prevention, Part 4: Reports of significant adverse drug events.

Kelly WN.

Am J Health Syst Pharm. 2001 Aug 1;58(15):1406-12. Review.

PMID:
11494785
[PubMed - indexed for MEDLINE]
12.

Nature of preventable adverse drug events in hospitals: a literature review.

Kanjanarat P, Winterstein AG, Johns TE, Hatton RC, Gonzalez-Rothi R, Segal R.

Am J Health Syst Pharm. 2003 Sep 1;60(17):1750-9. Review.

PMID:
14503111
[PubMed - indexed for MEDLINE]
13.

Drug-related problems in hospitals: a review of the recent literature.

Krähenbühl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S.

Drug Saf. 2007;30(5):379-407. Review.

PMID:
17472418
[PubMed - indexed for MEDLINE]
14.

Potential risks and prevention, Part 3: Drug-induced threats to life.

Marcellino K, Kelly WN.

Am J Health Syst Pharm. 2001 Aug 1;58(15):1399-405. Review.

PMID:
11494784
[PubMed - indexed for MEDLINE]
15.

Adverse drug events in the elderly.

Cresswell KM, Fernando B, McKinstry B, Sheikh A.

Br Med Bull. 2007;83:259-74. Epub 2007 Jun 18. Review.

PMID:
17580312
[PubMed - indexed for MEDLINE]
16.

[Patient safety and risk management].

Schrappe M.

Med Klin (Munich). 2005 Aug 15;100(8):478-85. Review. German.

PMID:
16096729
[PubMed - indexed for MEDLINE]
17.

Prevalence of adverse drug events in ambulatory care: a systematic review.

Taché SV, Sönnichsen A, Ashcroft DM.

Ann Pharmacother. 2011 Jul;45(7-8):977-89. doi: 10.1345/aph.1P627. Epub 2011 Jun 21. Review.

PMID:
21693697
[PubMed - indexed for MEDLINE]
18.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
19.

Potential risks and prevention, Part 2: Drug-induced permanent disabilities.

Kelly WN.

Am J Health Syst Pharm. 2001 Jul 15;58(14):1325-9. Review.

PMID:
11471480
[PubMed - indexed for MEDLINE]
20.

Ambulatory surgery: is the liability risk lower?

Metzner J, Kent CD.

Curr Opin Anaesthesiol. 2012 Dec;25(6):654-8. doi: 10.1097/ACO.0b013e3283592f90. Review.

PMID:
23128453
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk